YO-PRO 1
- ₹19089 - ₹25618.8
- Product name: YO-PRO 1
- CAS: 152068-09-2
- MF: C24H29IN3O+
- MW: 502.42
- EINECS:
- MDL Number:
- Synonyms:YO-PRO 1;Quinolinium, 4-((3-methyl-2(3H)-benzoxazolylidene)methyl)-1-(3-(trimethylammonio)propyl)-, diiodide;Yo;Yo-pro 1 iodide;Oxazole yellow >=98% (HPLC);Oxazole yellow, 1mM in DMSO;Oxazole yellow, ≥99%
2 prices
Selected condition:
Brand
- Sigma-Aldrich(India)
- ottokemi
Package
- 1MG
- ManufacturerSigma-Aldrich(India)
- Product numberSML1792
- Product descriptionOxazole yellow ≥98% (HPLC)
- Packaging1MG
- Price₹25618.8
- Updated2022-06-14
- Buy
- Manufacturerottokemi
- Product number O 0967
- Product descriptionOxazole yellow, ≥99%
- Packaging1mg
- Price₹19089
- Updated2022-05-26
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Sigma-Aldrich(India) | SML1792 | Oxazole yellow ≥98% (HPLC) | 1MG | ₹25618.8 | 2022-06-14 | Buy |
ottokemi | O 0967 | Oxazole yellow, ≥99% | 1mg | ₹19089 | 2022-05-26 | Buy |
Properties
Melting point :>250 ℃
storage temp. :2-8°C
solubility :H2O: soluble5, clear (warmed)
form :powder
color :yellow to orange-brown
λmax :491 nm
Biological Applications :Nucleic acid hybridization; nucleic acid sequencing; detecting nucleic acids,cells,bacteria,immunodeficiency virus,microorganisms; counting embryoblasts,viruses; apoptosis assay; white blood cell functional assay
storage temp. :2-8°C
solubility :H2O: soluble5, clear (warmed)
form :powder
color :yellow to orange-brown
λmax :491 nm
Biological Applications :Nucleic acid hybridization; nucleic acid sequencing; detecting nucleic acids,cells,bacteria,immunodeficiency virus,microorganisms; counting embryoblasts,viruses; apoptosis assay; white blood cell functional assay
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | ||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||
Precautionary statements: |
|